Buenaventura Collazos D, Aguilar Londoño C, Aristizábal-Henao N, Torres-Grajales J, Gutiérrez-Restrepo J. Lenvatinib dose-escalation therapy in a patient with papillary thyroid carcinoma after discontinuation due to a severe adverse event . Rev.ACE [Internet]. 2025 Jun. 30 [cited 2026 May 14];12(2). Available from: https://revistaendocrino.org/index.php/rcedm/article/view/934